Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-15

Clinical Trial Update: Letrozole and Misoprostol for Termination of Pregnancy up to 63 Days' Gestation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating letrozole and misoprostol for termination of pregnancy up to 63 days gestation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Letrozole (letrozole)
  • MISOPROSTOL (Misoprostol)

Snippet

Sponsor: Gynuity Health Projects | Conditions: Pregnancy | Phase 2 | Status: COMPLETED